Skip to main content

Prostate Cancer, Version 1.2016.

Publication ,  Journal Article
Mohler, JL; Armstrong, AJ; Bahnson, RR; D'Amico, AV; Davis, BJ; Eastham, JA; Enke, CA; Farrington, TA; Higano, CS; Horwitz, EM; Hurwitz, M ...
Published in: J Natl Compr Canc Netw
January 2016

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-naïve disease.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

January 2016

Volume

14

Issue

1

Start / End Page

19 / 30

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Prognosis
  • Orchiectomy
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Male
  • Humans
  • Disease Progression
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mohler, J. L., Armstrong, A. J., Bahnson, R. R., D’Amico, A. V., Davis, B. J., Eastham, J. A., … Freedman-Cass, D. A. (2016). Prostate Cancer, Version 1.2016. J Natl Compr Canc Netw, 14(1), 19–30. https://doi.org/10.6004/jnccn.2016.0004
Mohler, James L., Andrew J. Armstrong, Robert R. Bahnson, Anthony Victor D’Amico, Brian J. Davis, James A. Eastham, Charles A. Enke, et al. “Prostate Cancer, Version 1.2016.J Natl Compr Canc Netw 14, no. 1 (January 2016): 19–30. https://doi.org/10.6004/jnccn.2016.0004.
Mohler JL, Armstrong AJ, Bahnson RR, D’Amico AV, Davis BJ, Eastham JA, et al. Prostate Cancer, Version 1.2016. J Natl Compr Canc Netw. 2016 Jan;14(1):19–30.
Mohler, James L., et al. “Prostate Cancer, Version 1.2016.J Natl Compr Canc Netw, vol. 14, no. 1, Jan. 2016, pp. 19–30. Pubmed, doi:10.6004/jnccn.2016.0004.
Mohler JL, Armstrong AJ, Bahnson RR, D’Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Kane CJ, Kawachi MH, Kuettel M, Lee RJ, Meeks JJ, Penson DF, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M, Rosenfeld S, Schaeffer E, Skolarus TA, Small EJ, Sonpavde G, Srinivas S, Strope SA, Tward J, Shead DA, Freedman-Cass DA. Prostate Cancer, Version 1.2016. J Natl Compr Canc Netw. 2016 Jan;14(1):19–30.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

January 2016

Volume

14

Issue

1

Start / End Page

19 / 30

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Prognosis
  • Orchiectomy
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Male
  • Humans
  • Disease Progression
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis